On April 26th, Life Technologies released its earnings for the first quarter of 2011.
The results are summarized as follows:
Revenue for the first quarter was $897 million, an increase of 1 percent over the $887 million reported for the Q1 2010.
Organic growth was flat due to negative impact of Japan Earthquake, otherwise it would’ve been 5%.
Cell systems revenue rose 11% to $238 million, while genetic systems sales, hurt by delayed shipment of its new gene sequencer to Japan, fell 4% to $228 million.
Looking ahead, the company expects net income between $3.80 and $3.95 per share in 2011. Analysts expect net income of $3.87 per share.